Showing 4 of 4 recruiting trials for “hairy-cell-leukemia-variant”
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →